Martel

Value Lever Diagnostic

Which lever is worth the most, and can this platform actually move it?

Duration

6 to 8 weeks

Structure

One fixed fee

Output

The Value Lever Plan

Value Lever DiagnosticTransformation OfficeExit Readiness6 to 8 weeksSIGNCLOSETHE HOLDPROCESS

What it is

Every build starts from a sized lever. If you don't have one, this is how you get it. The diagnostic finds and sizes the platform's biggest value lever and hands you a board-ready plan: the sized prize, the targets, the build sequence. It speaks the language your IC already uses. Revenue growth, margin expansion, acquisitions, the multiple. Then it tells you which one this platform can actually move, what that is worth, and what it takes to capture it.

A thesis diagnostic, not a function audit

A thesis diagnostic, not a function audit

Bring in a payer-contracting shop and the answer is your rates. Bring in a growth consultancy and the answer is your pipeline. A single-function audit always finds its own function's problem. The finding is usually real. Whether it is the constraint actually capping the platform's value is a question that audit was never built to ask.

This diagnostic has no predetermined answer. It maps the four areas where a platform's value actually moves, goes deep where the evidence points, and sizes the lever the evidence implicates. It answers the two questions the deal model can't: can this platform execute the thesis, and what will it actually take to capture the value the model assumed?

What the diagnostic examines

Volume growth

Commercial infrastructure

Referral development, practice affiliation, and entry into new markets and service lines. The commercial data architecture underneath them.

Pricing optimization

Payer economics

Rate, mix, and capture, plus the move into risk and value-based contracts.

Operating leverage

Unit economics

Cost to serve by site, by service line, by patient, and the delivery capacity that sets it.

Inorganic growth

Add-on execution

Evaluation, qualification, diligence coordination, integration, post-close tracking.

Two ways platforms arrive

Two ways platforms arrive

The lever is named

Your team has already called it from the deal model. But a deal model names levers top-down, and named is not sized. Six weeks working bottom-up from the operating floor tells you what the lever is actually worth and whether the platform can capture it. You arrive with a name. You leave with a number and a plan.

The thesis is open

The platform isn't where the thesis needs it and no single lever has announced itself. Eight weeks: I baseline how the platform runs, triage all four areas, then size the one worth the most. You arrive with a problem. You leave with the lever, its number, and the sequence to capture it.

Three timings, one instrument

Three timings, one instrument

Pre-close

Sign-to-close, six to eight weeks, commissioned by the sponsor. The evidence comes from diligence and management rather than the operating floor. The plan lands before the platform is yours, so the hold opens with the build already scoped.

Post-close

The most common entry: the opening six to eight weeks of the hold, inside the first hundred days, with room to start the build.

Mid-hold

When the plan has slipped, the market has moved or the leadership has changed. The evidence is what the hold has produced so far, read against what the deal model assumed. The plan that comes out re-underwrites the thesis for the years left.

When this tends to be the right call

Pre-close

The LOI is signed and the value creation plan still names levers nobody has sized.

Diligence confirmed the numbers. Nobody has checked whether the platform can run the plan built on them.

After close

The hundred-day plan lists nine priorities and nobody has ranked them.

The deal model named the lever. No one at the platform can say how big it actually is.

Mid-hold

The fund and the CEO see the value in different places and nobody has had the time to build the case either way.

Two years in, the thesis needs re-underwriting, and the recovery plan behind it is too thin to underwrite.

Not needed

If the lever already has a number behind it and the team has built this before, skip the diagnostic and start the build.

What the plan looks like

What the plan looks like

A document your IC can read without translation. The sized prize up front: what the lever is worth and how the number was built. The targets underneath it. The build sequence with decision gates, and an honest read on what the platform's operating base can carry today and what it can't yet. Executable with or without me.

Value Lever Diagnostic
The sized prize, by value domain
Value domain
Run-rate EBITDA
Relative size
What the evidence showed
Payer economics
$8.6M
Taken to depth
Commercial rate sits 8 points under regional benchmark across two thirds of the book. (1)
Commercial infrastructure
$5.1M
Three referral sources produce 61% of new patients, none of them under contract.
Unit economics
$3.4M
Cost to serve varies 31% across sites with comparable case mix. (2)
Add-on execution
$1.2M
Two prior add-ons still run on separate instances, eighteen months after close.
Identified across the four domains
$18.3M
(1) Benchmark from regional commercial rate data; every domain normalized to one common ruler so the four are comparable. (2) Excludes the two sites acquired inside the trailing twelve months. Source: platform general ledger, contracted fee schedules and remittance detail, trailing twelve months. Figures preliminary and subject to the base reconciliation in phase one.
MartelIllustrative exampleValue Lever Diagnostic

What happens next

What happens next

The diagnostic defines the build. Fixed scope, signed off by both sides before it starts, and built in the Transformation Office. Or take the plan and run it with your own team. Either way, you spent a known, fixed fee to answer a question worth many multiples of it, before committing to a build.

What would you size first?

What would you size first?

Tell me about the platform and the thesis. I'll tell you where I'd look, and whether the diagnostic fits your window.

Start a Conversation

© 2026 Martel Health